Solvay’s Zeniva® polyetheretherketone (PEEK) resin was chosen by Carbon22 for its new Creed™ Cannulated Screw System for foot and ankle surgery. This new system recently received 510(k) clearance from FDA.
To create the system’s ortholucent, plastic-metal hybrid composite, Solvay’s implant-grade radiolucent Zeniva PEEK resin is overmolded onto a titanium core prior to final processing. This material allows the screw to be seen with x-ray or CT scanning while enabling the surgeon to assess anatomical details near and behind the implant site without visual distortion or artifacts.
“We worked closely with Carbon22 to achieve strong adhesion to titanium, which is not an inherent property of PEEK,” said Anna Maria Bertasa, Healthcare Global Marketing Manager for Solvay Specialty Polymers. “Solvay’s broad, deep technical expertise and advanced material technologies are what set us apart from our competition and enabled us to help create the innovative Creed™ system. We welcome new challenges that address the unique individual needs of our customers to give them a competitive advantage and help them succeed.”
“Solvay is a recognized industry leader for implantable PEEK,” said Vadim Gurevich, CEO of Carbon22. “Their team provided exceptional materials expertise and engineering capabilities that were instrumental in the development of our new Creed system. Together, we are actively engaged in new development projects that promise to further drive the development of next-generation orthopedic devices.”